Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 5/20 | 0.67 |
| ▸ | RARG | P13631 | 1/20 | 0.64 |
| ▸ | PLA2G4B | P0C869 | 6/20 | 0.60 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.55 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6539069 | 0.91 | TSHR (0.67) | RARBRARGPLA2G4BPLA2G4ATSHR | |
| SCHEMBL4187728 | 0.86 | KMT2A (0.55) | RARBRARGTSHRRECQLNPC1 | |
| SCHEMBL14112030 | 0.84 | RECQL (0.77) | TSHRRECQLNPC1 | |
| SCHEMBL10599988 | 0.84 | RECQL (0.77) | TSHRRECQLNPC1 | |
| SCHEMBL7195953 | 0.82 | TSHR (0.63) | TSHRRECQLITGB3ITGA2B | |
| SCHEMBL7195903 | 0.82 | TSHR (0.63) | TSHRRECQLITGB3ITGA2B | |
| SCHEMBL8366672 | 0.82 | RECQL (0.79) | TSHRRECQLNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4511288 | 0.82 | HTT (0.57) | PLA2G4BTSHRRECQLNPC1RAB9A | |
| SCHEMBL8943017 | 0.81 | RARB (1.00) | RARBPLA2G4BPLA2G4ATSHRTP53 | |
| SCHEMBL5858775 | 0.81 | RARB (1.00) | RARBPLA2G4BPLA2G4ATSHRTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090176837-A1 | COMPOUNDS WITH ACTIVITY AT RETINOIC ACID RECEPTORS | SONY CORPORATION (JP) | 2009-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176837-A1 | COMPOUNDS WITH ACTIVITY AT RETINOIC ACID RECEPTORS | RARB, RARA, RARG | RARB 1/4885RARG 3/4885PLA2G4B 507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.